Genomics

Dataset Information

0

PGRN-RIKEN-CALGB 40101 - Genome-wide Pharmacogenomic Study of Cyclophosphamide, Doxorubicin and Paclitaxel in Breast Cancer

ABSTRACT: PGRN-RIKEN-CALGB 40101 - Genome-wide Pharmacogenomic Study of Cyclophosphamide, Doxorubicin and Paclitaxel in Breast Cancer

PROVIDER: PRJNA262702 | ENA |

REPOSITORIES: ENA

Json Xml

Similar Datasets

Genomics PGRN-RIKEN-CALGB 80303 - Genome-wide Pharmacogenomic Study of Gemcitabine and Bevacizumab in Advanced Pancreatic Cancer
| PRJNA75653 | ENA
Genomics PGRN-RIKEN Mayo Breast Cancer
| PRJNA75545 | ENA
Genomics PGRN-RIKEN Mayo-NSABP Prevention Study
| PRJNA75693 | ENA
Genomics PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation
| PRJNA80275 | ENA
Genomics PGRN – RIKEN: Genetic Determinants of Clinical Cardiovascular Events in Patients Receiving Statins
| PRJNA290826 | ENA
Genomics PGRN-RIKEN:Genome-Wide Association Study of Drug-Induced Long-QT Syndrome
| PRJNA75677 | ENA
Genomics Homo sapiens
| PRJNA75655 | ENA
Genomics Homo sapiens
| PRJNA262703 | ENA
Genomics Homo sapiens
| PRJNA298270 | ENA
Genomics Homo sapiens
| PRJNA298271 | ENA